Merck Millipore acquires rights for Biotest microbiology products
Merck Millipore now has exclusive rights to sell Biotest microbiology products in Australia and New Zealand.
In 2011, Merck Millipore acquired German company Biotest, an innovative industrial microbiology company with capabilities in ready-to-use media and hygiene monitoring. Its products are targeted at the pharmaceutical and food and beverage segments.
Biotest’s microbiology products, previously marketed by either of their two trading companies, Heipha and Hycon, are now exclusively available through Merck Millipore. Technical support for the products is also offered.
Govt and industry fund health and biotech innovation in SEQ
The SEQ Innovation Economy Fund has awarded eight projects $94m in government funding, while...
Does the 2025–26 Budget do enough for science?
AAMRI has described the 2025–26 federal Budget as "very disappointing" for the...
Ming Long appointed Chair of CSIRO
Minister for Industry and Science Ed Husic has announced the appointment of Ming Long to the role...
